Risk level in pregnancy: This medicine is classified as Category B.
Has not been established the safety of this medication in pregnant women, as it lacks properly designed and controlled studies. p>
Studies in rats at doses nine times greater than those used in humans (480 mg / kg) have not detected alterations in fertility or harm to the fetus. In other laboratory animals is detected a decrease of the expected increase in weight, possibly due to the effect of high doses of acarbose on intestinal absorption. p>
Meaning of category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.